Wegovy, Ozempic maker to face off on Capitol Hill over high prices

In a new push to make popular weight loss drugs more affordable, the CEO of Novo Nordisk is set to face a grilling on Capitol Hill over the high cost of Ozempic, used to treat type 2 diabetes, and Wegovy which is approved for weight loss. NBC’s Christine Romans reports for TODAY.